HACE1
(HECT Domain and Ankyrin Repeat Containing, E3 Ubiquitin Protein Ligase 1 (HACE1))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-HACE1 antibody (Catalog #: ARP43277_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
HACE1
(HECT Domain and Ankyrin Repeat Containing, E3 Ubiquitin Protein Ligase 1 (HACE1))
Synonyme
HACE1 Peptide, 1700042J16Rik Peptide, A730034A22Rik Peptide, BC025474 Peptide, HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 Peptide, HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 L homeolog Peptide, HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 Peptide, HACE1 Peptide, hace1 Peptide, hace1.L Peptide, Hace1 Peptide
Hintergrund
HACE1 contains 6 ANK repeats and 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain. HACE1 is an E3 ubiquitin-protein ligase that may function in cellular proteins degradation.